Neuroscience

Targeting tau, the other protein behind Alzheimer's disease

In November, researchers reported the drug lecanemab slowed the progression of Alzheimer's disease. The effect was modest, but it has generated tremendous excitement because it was the first time a drug had been shown to ...

Neuroscience

New study sheds light on basic biology of frontotemporal dementia

Dementia encompasses a range of neurodegenerative conditions that lead to memory loss and cognitive deficiencies and affect some 55 million people worldwide. Yet despite its prevalence, there are few effective treatments, ...

Neuroscience

Five diseases attack language areas in brain

There are five different diseases that attack the language areas in the left hemisphere of the brain that slowly cause progressive impairments of language known as primary progressive aphasia (PPA), reports a new Northwestern ...

Alzheimer's disease & dementia

New computational model proposed for Alzheimer's disease

Mayo Clinic researchers have proposed a new model for mapping the symptoms of Alzheimer's disease to brain anatomy. This model was developed by applying machine learning to patient brain imaging data. It uses the entire function ...

page 3 from 19